packageNintedanib

nintedanib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Nintedanib is a protein kinase inhibitor used to treat idiopathic pulmonary fibrosis and other interstitial lung diseases, and also certain lung cancers. It is authorised in the European Union for several fibrotic lung conditions and non-small-cell lung cancer.

Summary written by glm-5.3-flash from Wikidata Q15149723 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:nintedanib
ATC codes:L01EX09, L01XE3
DrugBank:DB09079
PubChem CID:9809715
ChEBI:85164
Wikidata:Q15149723
formula:C31H33N5O4
molar mass:539.625 g/mol (knowledgebase (DrugBank calculated))
logP:4.3 (Drugs.Common 25.09, not verified)

Metabolites

BIBF1202BIBF 1202525.609 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
BIBF1202metabolite: BIBF 1202